Showing 69,781 - 69,800 results of 133,614 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.26s Refine Results
  1. 69781

    Data_Sheet_1_Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis.docx by Jalal A. Zahhar (17765295)

    Published 2024
    “…Overall, the studies showed a significant decrease in the risk of stroke incidence/hospitalization among vaccinated patients (OR = 0.81, 95% CI [0.77–0.86], p = 0.00001). …”
  2. 69782

    Image1_Identification of human pregnane X receptor antagonists utilizing a high-throughput screening platform.pdf by Caitlin Lynch (6051857)

    Published 2024
    “…Finally, HepaRG cells were used to confirm PXR antagonism by verification of a concentration-dependent decrease of CYP3A4 when co-treated with the known PXR agonist, rifampicin. …”
  3. 69783

    Image1_Enhancing decellularized vascular scaffolds with PVDF and PCL reinforcement: a fused deposition modeling approach.jpeg by Kirill Yu. Klyshnikov (11151429)

    Published 2023
    “…In contrast, both PVDF and PCL reinforced scaffolds did not exhibit significant property degradation, with deformations ranging 0.1–0.13 mm depending on the model, and a maximum decrease in the modulus of elasticity of 23%.…”
  4. 69784

    DataSheet_1_Projecting cancer prevalence by phase of care: a methodological approach for health service planning.pdf by Silvia Francisci (6527255)

    Published 2023
    “…</p>Results<p>Prevalence is expected to increase in 2015-2026 for all considered cancer sites and sexes, with average annual variations spanning from 2.6% for women with lung cancer to 0.5% for men with colorectal cancer. The only exception is lung cancer prevalence in men, which shows an average annual decrease of 1.9%. …”
  5. 69785

    Supplementary file 1_Biological effects of cinnamaldehyde in animal cancer models: a systematic review and meta-analysis.docx by Dan Luo (192943)

    Published 2025
    “…However, no improvement in survival was observed, and CA-treated animals showed a modest decrease in body weight. Additionally, reduced expression of proliferating cell nuclear antigen (PCNA), hypoxia-inducible factor (HIF), vascular endothelial growth factor (VEGF), and microvessel density was reported. …”
  6. 69786

    Impact of Metformin on Endothelial Ischemia-Reperfusion Injury in Humans In Vivo: A Prospective Randomized Open, Blinded-Endpoint Study by Saloua El Messaoudi (587363)

    Published 2014
    “…A linear mixed model analysis revealed that metformin treatment did not prevent the decrease in FMD by IR.…”
  7. 69787

    Table3_Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian Randomization study.DOCX by Rongkang Li (11865425)

    Published 2024
    “…</p>Results<p>Based on the IVW analysis, we identified a significant causal association between rosuvastatin use and a decreased risk of bladder cancer, with genetic analysis inferring the substantial reduction in odds (OR = 3.52E-19, 95% CI: 5.48E-32–2.26E-06, p = 0.005). …”
  8. 69788

    Table3_Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian Randomization study.DOCX by Rongkang Li (11865425)

    Published 2024
    “…</p>Results<p>Based on the IVW analysis, we identified a significant causal association between rosuvastatin use and a decreased risk of bladder cancer, with genetic analysis inferring the substantial reduction in odds (OR = 3.52E-19, 95% CI: 5.48E-32–2.26E-06, p = 0.005). …”
  9. 69789

    The Hydrophilic Phosphatriazaadamantane Ligand in the Development of H<sub>2</sub> Production Electrocatalysts:  Iron Hydrogenase Model Complexes by Rosario Mejia-Rodriguez (2674753)

    Published 2004
    “…The most effective electrocatalyst is the asymmetric <b>1-PTA </b>species, which promotes H<sub>2</sub> formation from HOAc (p<i>K</i><sub>a</sub> in CH<sub>3</sub>CN = 22.6) at −1.4 V in CH<sub>3</sub>CN/H<sub>2</sub>O mixtures at the Fe<sup>0</sup>Fe<sup>I</sup> redox level. …”
  10. 69790

    The Hydrophilic Phosphatriazaadamantane Ligand in the Development of H<sub>2</sub> Production Electrocatalysts:  Iron Hydrogenase Model Complexes by Rosario Mejia-Rodriguez (2674753)

    Published 2004
    “…The most effective electrocatalyst is the asymmetric <b>1-PTA </b>species, which promotes H<sub>2</sub> formation from HOAc (p<i>K</i><sub>a</sub> in CH<sub>3</sub>CN = 22.6) at −1.4 V in CH<sub>3</sub>CN/H<sub>2</sub>O mixtures at the Fe<sup>0</sup>Fe<sup>I</sup> redox level. …”
  11. 69791
  12. 69792
  13. 69793

    Evaluation of 309 Environmental Chemicals Using a Mouse Embryonic Stem Cell Adherent Cell Differentiation and Cytotoxicity Assay by Kelly J. Chandler (218453)

    Published 2011
    “…Increased transcriptional activity of several critical developmental genes including <em>BMPR2</em>, <em>PAX6</em> and <em>OCT1</em> were strongly associated with decreased ES cell differentiation. Multiple genes involved in reactive oxygen species signaling pathways (<em>NRF2</em>, <em>ABCG2</em>, <em>GSTA2</em>, <em>HIF1A</em>) were strongly associated with decreased ES cell differentiation as well. …”
  14. 69794

    DataSheet_1_The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis.docx by Sander Kuipers (16459287)

    Published 2023
    “…For every patient, Pareto-optimal plans were generated to explore the trade-off between rectum, bladder, and PB mean dose. The PB mean dose was decreased in steps of 1 Gy. …”
  15. 69795

    Example of a case of detected <i>EML4</i>-<i>ALK</i> fusion using multiplex PCR. by Yi-Lin Chen (428618)

    Published 2016
    “…The tumor size decreased from 2.4 cm to 1.5 cm (36%) after 6 months of TKI treatment.…”
  16. 69796
  17. 69797
  18. 69798
  19. 69799

    Optimization of the performance of a microbial fuel cell using the ratio electrode-surface area / anode-compartment volume by Eduardo D. Penteado (5138549)

    Published 2018
    “…Real wastewater coming from a winery factory was used and five ESAVRs were tested in separate MFCs, ranging from 0.15 to 0.75cm2cm-3. …”
  20. 69800

    DataSheet_1_CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathw... by Chaozheng Xie (13006614)

    Published 2022
    “…Reduced MIEF2 expression may enhance CRC resistance to OXL by reducing mitochondrial stability and inhibiting apoptosis by decreasing cytochrome C release. …”